EMA — authorised 10 November 2017
- Marketing authorisation holder: Janssen-Cilag International N.V.
- Status: approved
🇪🇺 Tremfya in European Union
EMA authorised Tremfya on 10 November 2017
Marketing authorisation
Tremfya in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in European Union
Frequently asked questions
Is Tremfya approved in European Union?
Yes. EMA authorised it on 10 November 2017.
Who is the marketing authorisation holder for Tremfya in European Union?
Janssen-Cilag International N.V. holds the EU marketing authorisation.